Prevalence and correlates of 25-hydroxyvitamin D deficiency in the Chronic Kidney Disease in Children (CKiD) cohort

Pediatric Nephrology

Volumn 31, Issue 1, 2016, Pages 121-129

  Kumar, Juhi ^a,h   McDermott, Kelly ^b   Abraham, Alison G ^b   Friedman, Lisa Aronson ^c   Johnson, Valerie L ^a   Kaskel, Frederick J ^d   Furth, Susan L ^e   Warady, Bradley A ^f   Portale, Anthony A ^g   Melamed, Michal L ^d  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h Albert Einstein College of Medicine/Montefiore Medical Center ^*  (United States)

Author keywords

Chronic renal disease; Fibroblast growth factor 23; Hyperparathyroidism; Mineral metabolism; Pediatric

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL; CALCIUM; CREATININE; FIBROBLAST GROWTH FACTOR 23; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D; 25-HYDROXYVITAMIN D; BIOLOGICAL MARKER; PTH PROTEIN, HUMAN;

AFRICAN AMERICAN; AGE DISTRIBUTION; ARTICLE; BODY MASS; CALCIUM BLOOD LEVEL; CHILD; CHRONIC KIDNEY DISEASE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHOSPHATE BLOOD LEVEL; POPULATION; PREVALENCE; PRIORITY JOURNAL; PROTEINURIA; RACE; RISK FACTOR; SECONDARY HYPERPARATHYROIDISM; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN SUPPLEMENTATION; WINTER; ADOLESCENT; AGE; ANALOGS AND DERIVATIVES; ANIMAL; BLOOD; CLINICAL TRIAL; DIETARY SUPPLEMENT; HYPERPARATHYROIDISM, SECONDARY; INFANT; LONGITUDINAL STUDY; MILK; MULTICENTER STUDY; NORTH AMERICA; NUTRITIONAL STATUS; PRESCHOOL CHILD; PROGNOSIS; PROSPECTIVE STUDY; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; SEASON; TIME FACTOR;

ADOLESCENT; AGE FACTORS; ANIMALS; BIOMARKERS; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; FEMALE; HUMANS; HYPERPARATHYROIDISM, SECONDARY; INFANT; LONGITUDINAL STUDIES; MALE; MILK; NORTH AMERICA; NUTRITIONAL STATUS; PARATHYROID HORMONE; PREVALENCE; PROGNOSIS; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; SEASONS; TIME FACTORS; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84947487987     PISSN: 0931041X     EISSN: 1432198X     Source Type: Journal    
DOI: 10.1007/s00467-015-3190-7     Document Type: Article

References (53)

1. (2013) U.S. Renal Data System, USRDS 2013 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States
2. Furth SL, Abraham AG, Jerry-Fluker J, Schwartz GJ, Benfield M, Kaskel F, Wong C, Mak RH, Moxey-Mims M, Warady BA (2011) Metabolic abnormalities, cardiovascular disease risk factors, and GFR decline in children with chronic kidney disease. Clin J Am Soc Nephrol 6:2132–2140
3. Mitsnefes M, Flynn J, Cohn S, Samuels J, Blydt-Hansen T, Saland J, Kimball T, Furth S, Warady B (2010) Masked hypertension associates with left ventricular hypertrophy in children with CKD. J Am Soc Nephrol 21:137–144
4. Alborzi P, Patel NA, Peterson C, Bills JE, Bekele DM, Bunaye Z, Light RP, Agarwal R (2008) Paricalcitol reduces albuminuria and inflammation in chronic kidney disease: a randomized double-blind pilot trial. Hypertension 52:249–255
5. Andress DL (2006) Vitamin D in chronic kidney disease: a systemic role for selective vitamin D receptor activation. Kidney Int 69:33–43
6. Atkinson MA, Melamed ML, Kumar J, Roy CN, Miller ER 3rd, Furth SL, Fadrowski JJ (2014) Vitamin D, race, and risk for anemia in children. J Pediatr 164(153–158), e151
7. Forman JP, Curhan GC, Taylor EN (2008) Plasma 25-hydroxyvitamin D levels and risk of incident hypertension among young women. Hypertension 52:828–832
8. Mizobuchi M, Morrissey J, Finch JL, Martin DR, Liapis H, Akizawa T, Slatopolsky E (2007) Combination therapy with an angiotensin-converting enzyme inhibitor and a vitamin D analog suppresses the progression of renal insufficiency in uremic rats. J Am Soc Nephrol 18:1796–1806
9. de Zeeuw D, Agarwal R, Amdahl M, Audhya P, Coyne D, Garimella T, Parving HH, Pritchett Y, Remuzzi G, Ritz E, Andress D (2010) Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study): a randomised controlled trial. Lancet 376:1543–1551
10. Teng M, Wolf M, Ofsthun MN, Lazarus JM, Hernan MA, Camargo CA Jr, Thadhani R (2005) Activated injectable vitamin D and hemodialysis survival: a historical cohort study. J Am Soc Nephrol 16:1115–1125
11. Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML (2009) Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001–2004. Pediatrics 124:e362–e370
12. Turer CB, Lin H, Flores G (2013) Prevalence of vitamin D deficiency among overweight and obese US children. Pediatrics 131:e152–e161
13. Hollis BW, Jacob AL, Sallman A, Santiz Z, Lambert PW (1982) Circulating vitamin D and its photoproduction in uremia. In: Norman AW, Schaefer K, Herrath D, Grigoleit H (eds) Vitamin D, chemical, biochemical and clinical endocrinology of calcium metabolism. Walter de Gruyter, Berlin, pp 1157–1161
14. Lambert PW, De Oreo PB, Fu IY, Kaetzel DM, von Ahn K, Hollis BW, Roos BA (1982) Urinary and plasma vitamin D3 metabolites in the nephrotic syndrome. Metab Bone Dis Relat Res 4:7–15
15. Urena-Torres P, Metzger M, Haymann JP, Karras A, Boffa JJ, Flamant M, Vrtovsnik F, Gauci C, Froissart M, Houillier P, Stengel B (2011) Association of kidney function, vitamin D deficiency, and circulating markers of mineral and bone disorders in CKD. Am J Kidney Dis 58:544–553
16. Mehrotra R, Kermah D, Budoff M, Salusky IB, Mao SS, Gao YL, Takasu J, Adler S, Norris K (2008) Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol 3:1144–1151
17. Levin A, Bakris GL, Molitch M, Smulders M, Tian J, Williams LA, Andress DL (2007) Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate early kidney disease. Kidney Int 71:31–38
18. LaClair RE, Hellman RN, Karp SL, Kraus M, Ofner S, Li Q, Graves KL, Moe SM (2005) Prevalence of calcidiol deficiency in CKD: a cross-sectional study across latitudes in the United States. Am J Kidney Dis 45:1026–1033
19. Damasiewicz MJ, Magliano DJ, Daly RM, Gagnon C, Lu ZX, Ebeling PR, Chadban SJ, Atkins RC, Kerr PG, Shaw JE, Polkinghorne KR (2012) 25-Hydroxyvitamin D levels and chronic kidney disease in the AusDiab (Australian Diabetes, Obesity and Lifestyle) study. BMC Nephrol 13:55
20. Isakova T, Gutierrez OM, Patel NM, Andress DL, Wolf M, Levin A (2011) Vitamin d deficiency, inflammation, and albuminuria in chronic kidney disease: complex interactions. J Ren Nutr 21:295–302
21. Ali FN, Arguelles LM, Langman CB, Price HE (2009) Vitamin D deficiency in children with chronic kidney disease: uncovering an epidemic. Pediatrics 123:791–796
22. Kalkwarf HJ, Denburg MR, Strife CF, Zemel BS, Foerster DL, Wetzsteon RJ, Leonard MB (2012) Vitamin D deficiency is common in children and adolescents with chronic kidney disease. Kidney Int 81:690–697
23. Menon S, Valentini RP, Hidalgo G, Peschansky L, Mattoo TK (2008) Vitamin D insufficiency and hyperparathyroidism in children with chronic kidney disease. Pediatr Nephrol 23:1831–1836
24. Stein DR, Feldman HA, Gordon CM (2012) Vitamin D status in children with chronic kidney disease. Pediatr Nephrol 27:1341–1350
25. Seeherunvong W, Abitbol CL, Chandar J, Zilleruelo G, Freundlich M (2009) Vitamin D insufficiency and deficiency in children with early chronic kidney disease. J Pediatr 154(906–911), e901
26. Center for Disease Control and Prevention (2000) Clinical Growth Charts Accessed March 15, 2012 at http://www.cdc.gov/growthcharts/.
27. Weng FL, Shults J, Herskovitz RM, Zemel BS, Leonard MB (2005) Vitamin D insufficiency in steroid-sensitive nephrotic syndrome in remission. Pediatr Nephrol 20:56–63
28. Freundlich M, Bourgoignie JJ, Zilleruelo G, Abitbol C, Canterbury JM, Strauss J (1986) Calcium and vitamin D metabolism in children with nephrotic syndrome. J Pediatr 108:383–387
29. Schwartz GJHG, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263
30. Furth SL, Cole SR, Moxey-Mims M, Kaskel F, Mak R, Schwartz G, Wong C, Munoz A, Warady BA (2006) Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol 1:1006–1015
31. Ersfeld DL, Rao DS, Body JJ, Sackrison JL Jr, Miller AB, Parikh N, Eskridge TL, Polinske A, Olson GT, MacFarlane GD (2004) Analytical and clinical validation of the 25 OH vitamin D assay for the LIAISON automated analyzer. Clin Biochem 37:867–874
32. Wagner D, Hanwell HE, Vieth R (2009) An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D. Clin Biochem 42:1549–1556
33. Hollis BW, Kamerud JQ, Kurkowski A, Beaulieu J, Napoli JL (1996) Quantification of circulating 1,25-dihydroxyvitamin D by radioimmunoassay with 125I-labeled tracer. Clin Chem 42:586–592
34. Schwartz GJ, Furth S, Cole SR, Warady B, Munoz A (2006) Glomerular filtration rate via plasma iohexol disappearance: pilot study for chronic kidney disease in children. Kidney Int 69:2070–2077
35. Schwartz GJ, Schneider MF, Maier PS, Moxey-Mims M, Dharnidharka VR, Warady BA, Furth SL, Munoz A (2012) Improved equations estimating GFR in children with chronic kidney disease using an immunonephelometric determination of cystatin C. Kidney Int 82:445–453
36. Lockitch G, Halstead AC, Albersheim S, MacCallum C, Quigley G (1988) Age- and sex-specific pediatric reference intervals for biochemistry analytes as measured with the Ektachem-700 analyzer. Clin Chem 34:1622–1625
37. Blum RE, Wei EK, Rockett HR, Langeliers JD, Leppert J, Gardner JD, Colditz GA (1999) Validation of a food frequency questionnaire in Native American and Caucasian children 1 to 5 years of age. Matern Child Health J 3:167–172
38. Centers for Disease Control and Prevention (2000) Clinical growth charts. http://www.cdc.gov/growthcharts/cdc_charts.htm
39. (2010) Institute of Medicine: Dietary reference intakes for calcium and vitamin D. Washington, DC, National Academy of Sciences
40. Portale AA, Wolf M, Juppner H, Messinger S, Kumar J, Wesseling-Perry K, Schwartz GJ, Furth SL, Warady BA, Salusky IB (2014) Disordered FGF23 and mineral metabolism in children with CKD. Clin J Am Soc Nephrol 9:344–353
41. Bikle DD, Gee E, Halloran B, Kowalski MA, Ryzen E, Haddad JG (1986) Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab 63:954–959
42. Powe CE, Evans MK, Wenger J, Zonderman AB, Berg AH, Nalls M, Tamez H, Zhang D, Bhan I, Karumanchi SA, Powe NR, Thadhani R (2013) Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 369:1991–2000
43. Denburg MR, Kalkwarf HJ, de Boer IH, Hewison M, Shults J, Zemel BS, Stokes D, Foerster D, Laskin B, Ramirez A, Leonard MB (2013) Vitamin D bioavailability and catabolism in pediatric chronic kidney disease. Pediatr Nephrol 28:1843–1853
44. Chesney RW, Rosen JF, Hamstra AJ, Smith C, Mahaffey K, DeLuca HF (1981) Absence of seasonal variation in serum concentrations of 1,25-dihydroxyvitamin D despite a rise in 25-hydroxyvitamin D in summer. J Clin Endocrinol Metab 53:139–142
45. Oliveri MB, Ladizesky M, Somoza J, Martinez L, Mautalen C (1990) Winter serum levels of 25-hydroxy-vitamin D in Ushuaia and Buenos Aires. Medicina (B Aires) 50:310–314
46. (2009) KDOQI Clinical Practice Guideline for Nutrition in Children with CKD: 2008 update. Executive summary. Am J Kidney Dis 53:S11–104.
47. Shroff R, Wan M, Gullett A, Ledermann S, Shute R, Knott C, Wells D, Aitkenhead H, Manickavasagar B, Van’t Hoff W, Rees L (2012) Ergocalciferol supplementation in children with CKD delays the onset of secondary hyperparathyroidism: a randomized trial. Clin J Am Soc Nephrol 7:216–223
48. Taal MW, Thurston V, McIntyre NJ, Fluck RJ, McIntyre CW (2014) The impact of vitamin D status on the relative increase in fibroblast growth factor 23 and parathyroid hormone in chronic kidney disease. Kidney Int 86:407–413
49. Hasegawa H, Nagano N, Urakawa I, Yamazaki Y, Iijima K, Fujita T, Yamashita T, Fukumoto S, Shimada T (2010) Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease. Kidney Int 78:975–980
50. Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro-o M, Mohammadi M, Sirkis R, Naveh-Many T, Silver J (2007) The parathyroid is a target organ for FGF23 in rats. J Clin Invest 117:4003–4008
51. Galitzer H, Ben-Dov IZ, Silver J, Naveh-Many T (2010) Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int 77:211–218
52. Komaba H, Goto S, Fujii H, Hamada Y, Kobayashi A, Shibuya K, Tominaga Y, Otsuki N, Nibu K, Nakagawa K, Tsugawa N, Okano T, Kitazawa R, Fukagawa M, Kita T (2010) Depressed expression of Klotho and FGF receptor 1 in hyperplastic parathyroid glands from uremic patients. Kidney Int 77:232–238
53. Perwad F, Zhang MY, Tenenhouse HS, Portale AA (2007) Fibroblast growth factor 23 impairs phosphorus and vitamin D metabolism in vivo and suppresses 25-hydroxyvitamin D-1alpha-hydroxylase expression in vitro. Am J Physiol Renal Physiol 293:F1577–F1583